FDA-cleared PreClara™ Ratio (sFlt-1/PlGF) biomarker test offers clinicians a crucial tool for managing hypertensive disorders of pregnancy, with potential significant cost savings and improved patient ...
DUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical ...
DUBLIN, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
Trinity Biotech (TRIB) has released an update. Trinity Biotech has made a strategic investment of $2.5 million to acquire a 12.5% equity stake in Novus Diagnostics, a company developing rapid sepsis ...
Trinity Biotech will make a $1.5M convertible note investment in imaware™ alongside lead investor McNair Interests to accelerate partnership commercialisation efforts with a pipeline of payor ...
Next-generation column technology enhances efficiency, expands recurring revenue potential, and strengthens Trinity Biotech’s competitive position in the $2B+ HbA1c market DUBLIN, Dec. 15, 2025 (GLOBE ...
REGENSBURG, Germany--(BUSINESS WIRE)--Transcatheter Technologies GmbH, an emerging medical device company that is developing a third-generation transcatheter aortic valve implantation (TAVI) ...
Delaware County Council is partnering with Trinity Health Mid-Atlantic to provide COVID-19 testing for six months in an action that is not expected to cost more than $135,000. Trinity will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results